Sun Park is Executive Vice President and Group Chief Financial Officer for Pharmaceutical Distribution & Strategic Global Sourcing.  Prior to being named to his current role in September 2018, he was Executive Vice President of Strategy and Development for AmerisourceBergen Corporation.  Before joining AmerisourceBergen in 2012, Mr. Park served in various leadership roles across corporate development, corporate strategy and R&D portfolio management at MedImmune, the global biologics division of AstraZeneca. Before joining MedImmune, he held positions at Charterhouse Group International and Merrill Lynch & Company.

Mr. Park graduated from Yale University and attained his Master’s degree in Biotechnology from The John Hopkins University.